Christian Herzog

High Impact

Assistant Professor

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

herzogchristian@uams.edu

31 h-index 93 pubs 2,901 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Christian Herzog's research focuses on understanding the molecular mechanisms underlying kidney diseases and acute kidney injury. His work has investigated novel antigens in primary membranous nephropathy and transforming growth factor beta receptor 3-associated membranous nephropathy. Herzog also studies the role of specific proteins, such as serine protease HTRA1 and insulin-like growth factor-binding protein 1 (IGFBP-1), as potential targets or prognostic biomarkers in kidney disease and acute kidney injury following cardiothoracic surgery. His recent publications also explore the development of autoantibodies related to SARS-CoV-2 infection, including ACE2 autoantibodies, and the identification of SOD1 as a prognostic biomarker for acute kidney injury.

Herzog leads a research group and has a publication record that includes work on immune responses. He has collaborated with researchers within the University of Arkansas for Medical Sciences, including Joseph H. Holthoff, Yanping Izak Harville, Aaron J. Storey, and J. Craig Forrest. His scholarly output is reflected in an h-index of 31 and over 2,900 citations across 93 publications.

Metrics

  • h-index: 31
  • Publications: 93
  • Citations: 2,901

Selected Publications

  • Proteomic Profiling of Complement Components in Glomerular Disease (2026) DOI
  • The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025) DOI
  • Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice (2025) DOI
  • FSGS in an Adult Transplant Recipient Possibly Linked to a New Antibody against WT1 (2024) DOI
  • SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023) DOI
  • Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry (2023) DOI
  • Urine Mass Spectrometry Can Distinguish Prerenal and Intrarenal AKI (2022) DOI
  • Minor Antigens in Membranous Nephropathy Identified by Mass Spectrometry (2022) DOI
  • Development of ACE2 autoantibodies after SARS-CoV-2 infection (2021) DOI
  • Transforming Growth Factor Beta Receptor 3 (TGFBR3)–Associated Membranous Nephropathy (2021) DOI
  • Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy (2021) DOI

Grants & Funding

  • Pilot: Glomerular biomarkers of progression in IgA nephropathy NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: University of Pennsylvania Co-Investigator
  • Meprin A Metalloproteinase in Acute Kidney Injury NIH Co-Investigator
  • A Device for Detection of Acute Kidney Injury NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: Nephsmart, LLC Principal Investigator
  • Factors Associated with Outcomes in Patients on Continuous Dialysis Dialysis Clinic, Inc. Principal Investigator
  • A Device for Detection of Acute Kidney Injury NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: Nephsmart, LLC Principal Investigator
  • Development of a Precision Medicine-Based Diagnostic Tool for Membranous Nephropathy NIH/National Institutes of Health - Pass Through: Arkana Laboratories Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics